Verona Pharma plc

VRNA

VRNA has 40 disclosed filings on Paydirt over the past 24 months from 11 corporate insiders: 2 purchases and 38 sales, 1 filed past the deadline. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Aug 1 2025 and filed Aug 5 2025. The most active filer was Mark W Hahn with 10 filings.

Add to watchlist

Filings, 24m

2 buys · 38 sells · 1 late

Traders, 24m

11 insiders

Volume, 24miDollar value disclosed in the window

$61.9M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Aug 1 2025

Filed Aug 5 2025

ADViAverage daily dollar volume

–

not on file

No price series on file for VRNA yet.

Volume by month

Buys $387K Sells $61.5M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

MH Mark W Hahn Chief Financial Officer 10 filings DZ David Zaccardelli President and CEO 10 filings KR Kathleen A. Rickard Chief Medical Officer 6 filings AF Andrew Fisher General Counsel 4 filings VS Vikas Sinha Director 3 filings CA Christina Ackermann Director 2 filings MA Michael Austwick Director 1 filing KC Kenneth Cunningham Director 1 filing

Recent filings

Martin EdwardsSALE Director $142K
10,808 sh × $13.14
Exec Aug 1 2025
Filed Aug 5 2025 · 5:30 PM ET David ZaccardelliSALE President and CEO $2.7M
208,912 sh × $13.14
Exec Aug 1 2025
Filed Aug 5 2025 · 5:30 PM ET Michael AustwickSALE Director $148K
11,288 sh × $13.14
Exec Aug 1 2025
Filed Aug 5 2025 · 5:30 PM ET Kathleen A. RickardSALE Chief Medical Officer $767K
58,336 sh × $13.14
Exec Aug 1 2025
Filed Aug 5 2025 · 5:30 PM ET Mark W HahnSALE Chief Financial Officer $2.7M
208,912 sh × $13.14
Exec Aug 1 2025
Filed Aug 5 2025 · 5:30 PM ET Andrew FisherSALE General Counsel $126K
9,584 sh × $13.14
Exec Aug 1 2025
Filed Aug 5 2025 · 5:30 PM ET Lisa DeschampsSALE Director $124K
9,464 sh × $13.14
Exec Aug 1 2025
Filed Aug 5 2025 · 5:30 PM ET Kenneth CunninghamSALE Director $142K
10,808 sh × $13.14
Exec Aug 1 2025
Filed Aug 5 2025 · 5:30 PM ET Andrew FisherSALE General Counsel $922K
80,000 sh × $11.53
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET David ZaccardelliSALE President and CEO $4.6M
400,000 sh × $11.40
Exec Jun 11 2025
Filed Jun 13 2025 · 5:30 PM ET Mark W HahnSALE Chief Financial Officer $4.6M
400,000 sh × $11.40
Exec Jun 11 2025
Filed Jun 13 2025 · 5:30 PM ET David ZaccardelliSALE President and CEO $3.7M
400,000 sh across 3 lots
Exec May 27 2025
Filed May 29 2025 · 5:30 PM ET Mark W HahnSALE Chief Financial Officer $3.7M
400,000 sh across 3 lots
Exec May 27 2025
Filed May 29 2025 · 5:30 PM ET Vikas SinhaSALE Director $1.4M
160,000 sh across 2 lots
Exec Apr 29 2025
Filed May 22 2025 · 5:30 PM ET † Vikas SinhaSALE Director $1.5M
160,000 sh × $9.39
Exec May 20 2025
Filed May 22 2025 · 5:30 PM ET Christina AckermannSALE Director $338K
40,000 sh × $8.44
Exec May 14 2025
Filed May 16 2025 · 5:30 PM ET Andrew FisherSALE General Counsel $686K
80,000 sh × $8.57
Exec May 15 2025
Filed May 16 2025 · 5:30 PM ET Kathleen A. RickardSALE Chief Medical Officer $1.0M
114,984 sh × $8.82
Exec May 6 2025
Filed May 8 2025 · 5:30 PM ET David ZaccardelliSALE President and CEO $5.3M
587,008 sh across 3 lots
Exec May 1 2025
Filed May 5 2025 · 5:30 PM ET Mark W HahnSALE Chief Financial Officer $5.3M
587,008 sh across 3 lots
Exec May 1 2025
Filed May 5 2025 · 5:30 PM ET Kathleen A. RickardSALE Chief Medical Officer $440K
49,200 sh across 2 lots
Exec May 1 2025
Filed May 5 2025 · 5:30 PM ET Vikas SinhaSALE Director $134K
15,048 sh × $8.92
Exec Apr 29 2025
Filed May 1 2025 · 5:30 PM ET Mark W HahnSALE Chief Financial Officer $811K
90,360 sh × $8.98
Exec Apr 29 2025
Filed May 1 2025 · 5:30 PM ET Kathleen A. RickardSALE Chief Medical Officer $309K
34,384 sh × $8.98
Exec Apr 29 2025
Filed May 1 2025 · 5:30 PM ET David ZaccardelliSALE President and CEO $811K
90,360 sh × $8.98
Exec Apr 29 2025
Filed May 1 2025 · 5:30 PM ET